Omron (OTCMKTS:OMRNY) Stock Price Up 23.7% – Still a Buy?

Omron Corp. (OTCMKTS:OMRNY)’s stock price traded up 23.7% during mid-day trading on Monday . The company traded as high as $31.51 and last traded at $31.51. 1,303 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 45,504 shares. The stock had previously closed at $25.4750.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Omron from a “strong sell” rating to a “hold” rating in a report on Monday, January 19th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

Omron Stock Up 6.7%

The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.40 and a current ratio of 2.14. The company’s fifty day moving average price is $25.62 and its 200-day moving average price is $26.39. The stock has a market cap of $6.56 billion, a P/E ratio of 40.27, a price-to-earnings-growth ratio of 0.47 and a beta of 0.98.

Omron (OTCMKTS:OMRNY) last announced its earnings results on Thursday, February 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.19). Omron had a net margin of 2.80% and a return on equity of 2.46%. The business had revenue of $1.41 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Equities analysts forecast that Omron Corp. will post 0.42 EPS for the current year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC lifted its position in shares of Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,129 shares of the company’s stock after buying an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent quarter. 1.09% of the stock is currently owned by institutional investors and hedge funds.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.